Age: 47.0
Sex: U
Vaccine: COVID19
Symptoms: Paraesthesia oral, Pharyngeal swelling, Pruritus, Swelling, Swelling face
Clinical narrative: scared; swollen face, neck, throat, eyes, lips; swollen face, neck, throat, eyes, lips; swollen face, neck, throat, eyes, lips; terrible headache pressure; terrible headache pressure; spread to face with eyes swelling shut, lips tingling; burning flush and itchy; spread to face with eyes swelling shut, lips tingling; burning flush and itchy; spread to face with eyes swelling shut, lips tingling; burning flush and itchy; Burning flush; flush; worse/symptoms worsen; delayed drug sensitive; itching limbs; took the first dose on 16Mar2021 and the second dose on 26Mar2021; took the first dose on 16Mar2021 and the second dose on 26Mar2021; This is a spontaneous report from a contactable consumer (patient). A 47-year-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), second dose via an unspecified route of administration, administered in the right arm on 26Mar2021 12:45 (lot number and expiration date were not reported) as single dose (at the age of 47-years-old) for COVID-19 immunisation, administered in a pharmacy/drug store. Medical history included epstein-barr virus infection (EBV infection), high blood pressure (BP), exercise induced asthma and allergies to penicillin; all from an unknown date and unknown if ongoing. Concomitant medications included metoprolol succinate at 25 mg and hydrochlorothiazide, losartan potassium (LOSARTAN/HYDROCHLOORTHIAZIDE); both taken for an unspecified indication, start and stop date were not reported. The patient previously took tetracycline, prednisone and methylprednisolone acetate (MEDROL) and experienced allergies. The patient had no other vaccine in four weeks. The patient did not have COVID prior to vaccination and has not tested for COVID post vaccination. The patient took the first dose of BNT162B2 first dose on the right arm, on 16Mar2021 12:00 (at the age of 47-years-old, unknown lot number and expiration date) for covid-19 immunisation. The patient took the first dose on 16Mar2021 and the second dose on 26Mar2021 (pending clarification). The patient was given the shot on Friday (26Mar2021) noon/pm. The patient experienced the events starting on 16Apr2021 at 6 pm itching limbs. Saturday morning (17Apr2021), worse known delayed drug sensitive. The patient took 2 BENADRYL, every 4 hours. On Sunday (18Apr2021), the patient felt okay and discontinued BENADRYL. "Urgi" med Monday evening (19Apr2021) spread to face with eyes swelling shut, lips tingling; burning flush and itchy. The patient was given dexamethasone shot and given prednisone. The patient forgot that the patient was sensitive and called doctor for advice. The patient was advised to keep on with the BENADRYL at first sign of distress call. On Tuesday (20Apr2021), the patient was in distress and sent to ER because the patient felt there was no alternative treatment other than prednisone. "Urgi" doctor agreed to send the patient out of ER with MEDROL pack assuring it was fine. The patient took the first MEDROL with BENADRYL. The patient woke up Wednesday (21Apr2021) morning feeling okay. Took MEDROL without BENADRYL. By Thursday morning (22Apr2021), the patient was rushed to doctor with a swollen face, neck, throat, eyes, lips with terrible headache pressure. Another "dex shot" was given. Followed by oral "dex", ZYRTEK 2x BENADRYL as needed. Last pm, the patient was back at ER and was told that unless the patient had to inject themselves and called, the patient will not be admitted. On Friday (23Apr2021), day 7, BENADRYL wears and symptoms worsen. The patient was scared. The patient's adverse events resulted in a doctor clinic visit, emergency room and was considered a life-threatening illness by the reporter. The patient has not recovered from the events.   Information on the lot/batch number has been requested.